SPRC
SciSparc Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.44
−15.29%Margins
Gross margin
64.5%
EBITDA margin
-640.6%
EBIT margin
-660.5%
Net margin
-1210.9%
FCF margin
-859.6%
-208.4%
Return on equity
-44.5%
Return on assets
-67.7%
Return on invested capital
0.05x
Asset turnover
-$5.8M
Cash from operations
$7.64
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026